Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hyperliquid Strategies Inc (PURR)

Hyperliquid Strategies Inc (PURR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hyperliquid Strategies Inc 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 USA

www.sonnetbio.com Employees: 13 P: 609-375-2227

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Sonnet BioTherapeutics Holdings Inc. is an oncology-focused biotechnology company with a proprietary platform for biologic drugs of single or bispecific action. Sonnet BioTherapeutics Holdings Inc., formerly known as Chanticleer Holdings Inc., is based in PRINCETON, N.J.

Key Statistics

Overview:

Market Capitalization, $K 26,188
Enterprise Value, $K 26,038
Shares Outstanding, K 7,078
Annual Sales, $ 20 K
Annual Net Income, $ -7,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,490 K
EBIT, $ -13,780 K
EBITDA, $ -13,700 K
60-Month Beta 1.48
% of Insider Shareholders 8.48%
% of Institutional Shareholders 9.45%
Float, K 6,478
% Float 91.52%
Short Volume Ratio 0.60

Growth:

1-Year Return -3.97%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -99.93%
5-Year Earnings Growth 99.99%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.95 on 08/13/25
Next Earnings Date 12/16/25 [--]
Earnings Per Share ttm -8.05
EPS Growth vs. Prev Qtr -6.74%
EPS Growth vs. Prev Year 83.04%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PURR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -4,646.10%
Return-on-Assets % -342.21%
Profit Margin % -37,200.00%
Debt/Equity 0.00
Price/Sales 26.19
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.21
Interest Coverage -0.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar